Glaukos Corp Lowers Revenue Expectation, 16-Quarter Streak Coming to an End?
Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations.
The company’s …
Intercept Pharmaceuticals Stock Is Falling Today, Here’s Why
As of 10:30 a.m. EDT, shares of Intercept Pharmaceuticals (NASDAQ:$ICPT) declined by 17%. Why? Many speculate the fall was caused by a letter that was sent by Intercept’s Chief Medical Officer to the medical community …
Teva Pharmaceutical Shares Surged Today, Here’s Why
On Monday, September 11, after Teva Pharmaceutical announced that it had officially filled its open CEO seat, shares of the pharmaceutical company increased 18%.
What Happened?
The Israel-based company disclosed today that it …
Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds
A clinical-stage biotech company advancing novel therapies for skin-related diseases, Idera Pharmaceuticals Inc. (NASDAQ:$IDRA) saw its shares surge today. This came after the company presented trial results at the annual European Society for Medical Oncology …
Wall Street’s Bull of The Day: Kura Oncology
Kura Oncology Inc. (NASDAQ:$KURA)’s shares are up 90%, rightfully deserving of Wall Street’s bull of the day title. What’s their secret? The biotech company announced positive top-line results from a phase II trial for its …
Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report
Plummeting 6.8%, way outperforming the market, Immune Design Corp. (NASDAQ:$IMDZ)’s shares are suffering a serious outlook.
Let’s take a look back on Immune Design’s last earnings report.
Narrower-than-expected Loss in Q2
…
This Part of Bioverativ’s Pipeline Could Be a Key Driver For Long-Term Growth
Just last month, Bioverativ (NASDAQ:$BIVV) and Invicro signed a strategic collaboration in developing advanced imaging technologies for the diagnosis and treatment of joint diseases for patients with hemophilia.
In June 2017, Bioverativ acquired …
Gilead Sciences Stock Finally Sees New Uptrend Amid Multi-Year Lows
After a long slump of near multi-year lows, biotech giant Gilead Sciences Inc. (NASDAQ:$GILD), finally saw a recent breakout. This has led to significant buying interest that has lifted the stock into an uptrend that …
Why Sarepta Therapeutics Stock Rose 11% Today
During Wednesday Morning trading, Sarepta Therapeutics (NASDAQ:$SRPT) rose almost 11% on elevated volume. The stock’s outstanding performance undeniably was encouraged by news of optimal results from an early-stage muscle biopsy study for its experimental Duchenne …
Lung Disease Drug Sends Insmed’s Stock Soaring
As of pre-market trading Tuesday, shares of Insmed Inc. (NASDAQ:$ INSM) more than doubled. This came after the company announced that its new drug, an inhaled antibiotic known as Alis, successfully treated patients with a …